“Leaked Anthropic Financials, Oura Ring Delays IPO, & America.gov”
$LLYBullish
LLY's Retatrotide drug (28% weight loss) drove a 25-28% profit on the speaker's LLY position; the drug is generating significant positive buzz.
You know that you will lose 20% of your weight using one of these GLP-1 drugs, from Eli Lilly, Novo Nordisk , or Regeneron.
Eli Lilly's retatrotide drug achieved a 28% weight loss, with patients reporting improvements in daily mobility.